Follow the 아이큐어 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 아이큐어 has published 56 public disclosures. Market capitalisation: €81.1bn. The latest transaction was reported on 19 March 2026 (Other). Among the most active insiders: 최영권. Every trade is free.
52
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Fundamental score
Ranked 28,713 of 29,062 companies
7.9
score / 100
Value
11
Quality
5
FCF yld-10%
Earn yld-41%
EV/EBITDA·
ROE-76%
Gross mgn5.3%
Net mgn-40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
아이큐어 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de medicamentos y soluciones terapéuticas innovadoras.